David H. Abramson

19.9k total citations · 1 hit paper
400 papers, 12.0k citations indexed

About

David H. Abramson is a scholar working on Ophthalmology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David H. Abramson has authored 400 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 354 papers in Ophthalmology, 124 papers in Oncology and 81 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David H. Abramson's work include Ocular Oncology and Treatments (330 papers), Cancer-related Molecular Pathways (75 papers) and Glioma Diagnosis and Treatment (69 papers). David H. Abramson is often cited by papers focused on Ocular Oncology and Treatments (330 papers), Cancer-related Molecular Pathways (75 papers) and Glioma Diagnosis and Treatment (69 papers). David H. Abramson collaborates with scholars based in United States, Argentina and China. David H. Abramson's co-authors include Ira J. Dunkel, Jasmine H. Francis, Scott E. Brodie, Brian P. Marr, Y. Pierre Gobin, R. M. Ellsworth, Guillermo Chantada, Amy C Schefler, Christopher M. Frank and Robert M. Ellsworth and has published in prestigious journals such as Nature, Cell and JAMA.

In The Last Decade

David H. Abramson

376 papers receiving 11.5k citations

Hit Papers

Retinoblastoma 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Retinoblastoma
    2015 368 citations David H. Abramson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David H. Abramson 9.6k 3.6k 2.7k 2.6k 2.3k 400 12.0k
Arun D. Singh 6.9k 0.7× 2.9k 0.8× 1.9k 0.7× 848 0.3× 2.5k 1.1× 443 9.3k
Ira J. Dunkel 3.1k 0.3× 1.6k 0.4× 1.1k 0.4× 1.9k 0.7× 1.7k 0.7× 248 7.7k
Luther W. Brady 1.7k 0.2× 2.9k 0.8× 2.1k 0.8× 4.4k 1.7× 853 0.4× 342 10.1k
François Doz 2.3k 0.2× 1.8k 0.5× 652 0.2× 2.0k 0.8× 2.2k 1.0× 324 8.3k
John D. Earle 2.1k 0.2× 1.6k 0.5× 1.1k 0.4× 2.1k 0.8× 826 0.4× 127 6.9k
Tero Kivelä 5.4k 0.6× 1.8k 0.5× 2.2k 0.8× 607 0.2× 2.5k 1.1× 254 8.0k
James J. Augsburger 6.0k 0.6× 1.6k 0.4× 1.8k 0.7× 556 0.2× 1.4k 0.6× 269 7.2k
Murali Chintagumpala 765 0.1× 1.3k 0.4× 462 0.2× 2.4k 0.9× 3.1k 1.3× 231 8.3k
Arnold M. Markoe 846 0.1× 1.1k 0.3× 1.1k 0.4× 1.6k 0.6× 515 0.2× 203 4.9k
Karin Dieckmann 538 0.1× 2.2k 0.6× 1.2k 0.5× 3.1k 1.2× 782 0.3× 216 6.5k

Countries citing papers authored by David H. Abramson

Since Specialization
Citations

This map shows the geographic impact of David H. Abramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Abramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Abramson more than expected).

Fields of papers citing papers by David H. Abramson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Abramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Abramson. The network helps show where David H. Abramson may publish in the future.

Co-authorship network of co-authors of David H. Abramson

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Abramson. A scholar is included among the top collaborators of David H. Abramson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Abramson. David H. Abramson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Hang, Sheng Huang, Francis T. S. Yu, et al.. (2025). Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapy. Radiation Oncology. 20(1). 48–48.
2.
Dermawan, Josephine K., David H. Abramson, Sarah Chiang, et al.. (2024). The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations. Clinical Cancer Research. 30(20). 4780–4790. 1 indexed citations
3.
Francis, Jasmine H., et al.. (2024). Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal Infiltrates. Ophthalmology Retina. 9(6). 580–588.
4.
Elahi, Abul, Xiaoliang L. Xu, Alexia Eliades, et al.. (2023). Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-Related cancers: A brief review of current status and future prospects. Advances in Biological Regulation. 88. 100964–100964. 1 indexed citations
5.
Francis, Jasmine H., William Foulsham, James J. Harding, et al.. (2023). Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?. Ocular Oncology and Pathology. 9(1-2). 25–31. 1 indexed citations
6.
Foulsham, William, et al.. (2022). Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition. American Journal of Ophthalmology Case Reports. 27. 101657–101657. 4 indexed citations
7.
Bakhoum, Mathieu F., Jasmine H. Francis, Albert S. Agustinus, et al.. (2021). Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression. Nature Communications. 12(1). 5402–5402. 35 indexed citations
8.
Pierce, Janene, Yuankai K. Tao, Sheau‐Chiann Chen, et al.. (2021). Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Experimental Eye Research. 204. 108439–108439. 11 indexed citations
9.
Wijsard, Milo van Hoefen, Sara J. Schonfeld, Flora E. van Leeuwen, et al.. (2021). Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers. 13(8). 1773–1773. 4 indexed citations
10.
Abramson, David H., Diana Mandelker, Jasmine H. Francis, et al.. (2021). Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma. SHILAP Revista de lepidopterología. 1(1). 100015–100015. 17 indexed citations
11.
Francis, Jasmine H., et al.. (2020). Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. PLoS ONE. 15(7). e0235016–e0235016. 8 indexed citations
12.
Marass, Francesco, Julie L. Yang, Caitlin M. Stewart, et al.. (2020). Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience. Cancer Medicine. 9(17). 6093–6101. 35 indexed citations
13.
Fuentes, Federico, et al.. (2019). Tridimensional Retinoblastoma Cultures as Vitreous Seeds Models for Live-Cell Imaging of Chemotherapy Penetration. International Journal of Molecular Sciences. 20(5). 1077–1077. 18 indexed citations
14.
Francis, Jasmine H., Sofia Haque, Ira J. Dunkel, et al.. (2019). Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma. Ophthalmology Retina. 4(3). 327–335. 10 indexed citations
15.
Abramson, David H., et al.. (2018). Fabrication of a custom brachytherapy appliance. Journal of Prosthetic Dentistry. 121(3). 535–537. 2 indexed citations
16.
17.
Daniels, Anthony B., Y. Pierre Gobin, Brian P. Marr, et al.. (2014). Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma. Investigative Ophthalmology & Visual Science. 55(13). 3090–3090. 1 indexed citations
18.
Patel, Mrinali, Elizabeth Smyth, Paul B. Chapman, et al.. (2011). Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma. Clinical Cancer Research. 17(8). 2087–2100. 83 indexed citations
19.
Brodie, Scott E., Y. Pierre Gobin, Brian P. Marr, Ira J. Dunkel, & David H. Abramson. (2010). ERG Monitoring of Retinal Function After Super-Selective Intra-Arterial Chemotherapy for Retinoblastoma: 3-Year Results. Investigative Ophthalmology & Visual Science. 51(13). 3277–3277.
20.
Barbazetto, Irene, et al.. (2003). Treatment of Conjunctival Squamous Cell Carcinoma with Photodynamic Therapy - First Results. Investigative Ophthalmology & Visual Science. 44(13). 2435–2435. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun D. Singh Breakdown of academic impact, for papers by Ira J. Dunkel Breakdown of academic impact, for papers by Luther W. Brady Breakdown of academic impact, for papers by François Doz Breakdown of academic impact, for papers by John D. Earle Breakdown of academic impact, for papers by Tero Kivelä Breakdown of academic impact, for papers by James J. Augsburger Breakdown of academic impact, for papers by Murali Chintagumpala Breakdown of academic impact, for papers by Arnold M. Markoe Breakdown of academic impact, for papers by Karin Dieckmann
Rankless by CCL
2026